[Event Report] Invitation to Global Expert Meeting on Developed cases of public-private partnership for promoting measures against dementia (March 17, 2017)
date : 3/17/2017
Tags: Dementia
HGPI has been conducting research on the creation and use of public private partnerships for dementia research at the request of the Japan Agency for Medical Research and Development (AMED). Through this research, HGPI is proposing models for PPP that can promote effective and efficient dementia research. These models thoroughly consider the various needs of dementia research as well as international collaborations, and utilize both public and private funding. HGPI’s goal is for this research to lead to the construction and utilization of a concrete framework for dementia research in Japan.
For this event, HGPI invited a support group for dementia patients in the United Kingdom, Dementia UK, an Alzheimer research group, Alzheimer’s Research UK, and experts on dementia from Asia. HGPI shared examples and lessons learned from successful cases in which public-private partnerships were used to promote measures on dementia.
Speaker 1: Karen Harrison Dening
(Head of Research & Evaluation, Dementia UK)
Speaker 2: DY Suharya
(Creator and Executive Director, Alzheimer Indonesia)
Speaker 3: Li-Yu Tang
(Secretary General, Taiwan Alzheimer Association)
Speaker 4: Matthew Norton
(Head of Policy & Public Affair, Alzheimer’s Research UK)
Thursday, March 30
Guest Speaker Matthew Norton has kindly shared the blog he writes for Alzheimer’s Research UK. Please click here for further details
Exhibition date:2017-03-17
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)